Role of risk assessment using lipid ratios and adiposity markers in young patients with a first acute coronary syndrome
Abstract Funding Acknowledgements Type of funding sources: None. Background/Introduction Low-density lipoprotein cholesterol (LDL-C) remains the gold standard for lipid assessment in atherosclerotic cardiovascular disease (ASCVD). Recent guidelines remark the importance of non-high-density lipoprote...
Gespeichert in:
Veröffentlicht in: | European journal of preventive cardiology 2023-05, Vol.30 (Supplement_1) |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract
Funding Acknowledgements
Type of funding sources: None.
Background/Introduction
Low-density lipoprotein cholesterol (LDL-C) remains the gold standard for lipid assessment in atherosclerotic cardiovascular disease (ASCVD). Recent guidelines remark the importance of non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B (ApoB) in lipid risk assessment. Moreover, lipid ratios (LR) add information about small, dense LDL-C and other atherogenic lipoproteins. The presence of adiposity confers a higher metabolic and lipidic risk.
Purpose
To describe ApoB, non-HDL-C, remnant cholesterol (RC) and lipid ratios (LR) in young patients admitted for a first acute coronary syndrome (ACS); and to correlate those values with body mass index (BMI) and glycated haemoglobin (HbA1c) as adiposity and metabolic syndrome markers.
Methods
We performed a descriptive and retrospective study including 51 patients under 65 years old, admitted to hospital between July 2022 and October 2022, for an ACS irrespective of the onset (unstable angina, non-ST-segment or ST-segment elevation myocardial infarction (NSTEMI, STEMI)). We assessed a basic lipid profile including, HbA1c, total cholesterol (TC), LDL-C, HDL-C, triglycerides (TG) and ApoB. Non-HDL-C, RC and the following LR (TC/HDL-C, TG/HDL-C, LDL-C/HDL-C, non-HDL-C/HDL-C, LDL-C/ApoB, TC/ApoB and TG/ApoB) were estimated.
Results
In our study. 76,5% were male. Mean age was 56,1 years (± 7,3). The percentage of history of risk factors was: smoking 68,6%, hypertension 52,9%, diabetes 31,4%, dyslipidaemia 43,1%. 30 patients had STEMI (58,8%), 17 NSTEMI (33,3%). Mean BMI and HbA1c were 29,46 kg/m2 (±5,9) and 6,1% (±1,07), respectively. Mean waist circumference was 98 cm (±13,95) Mean values of the lipid profile were: LDL-C 89,74 mg/dL (±35,58), HDL-C 33,8 mg/dL (±8,4), TG 161,14 mg/dL (±66,26), non-HDL-C 122,28 mg/dL (±38,96), RC 32,54 mg/dL (±14,86), ApoB 97,6 mg/dL (±26,88). Mean LR were: TG/HDL-C 5,04 (±2,33), LDLc/ApoB 0,92 (±0.2). The rest of the characteristics and results are shown in Table 1.
We found statistically significant positive correlation between: TG and ApoB (r: 0,345; P=0,014); TG and TC/HDL-C ratio (r:0,326; P=0,21); TG and HbA1c (r: 0,349; P=0,02); TG an RC (r: 0,978; P |
---|---|
ISSN: | 2047-4873 2047-4881 |
DOI: | 10.1093/eurjpc/zwad125.217 |